beta-carboxylic acid esterified D-Asp-Ala retains a high affinity for the oligopeptide transporter in Caco-2 monolayers

被引:14
作者
Taub, ME
Larsen, BD
Steffansen, B
Frokjaer, S
机构
[1] ROYAL DANISH SCH PHARM, INST PHARM, DEPT PHARMACEUT, DK-2100 COPENHAGEN O, DENMARK
[2] KVL, DEPT CHEM, DK-1871 FREDERIKSBERG C, DENMARK
关键词
Caco-2; uptake; oligopeptide transporter; dipeptides; beta-carboxylic acid;
D O I
10.1016/S0378-5173(96)04802-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
D-Asp-Ala, a metabolically stable dipeptide, possesses a relatively high affinity for the Caco-2 oligopeptide transporter (IC50 = 5.75 +/- 0.09 mM) as demonstrated by its ability to compete with [C-14]Gly-Sar in cellular uptake experiments. When the beta-carboxylic acid of D-Asp-Ala is modified by esterification with a cyclohexyl group (D-Asp(OcHx)-Ala) or a benzyl group (D-Asp(OBzl)-Ala), the resulting compounds are still able to inhibit [C-14]Gly-Sar binding to the oligopeptide transporter, i.e., IC50 values for D-Asp(OcHx)-Ala and D-Asp(OBzl)-Ala were 2.80 +/- 0.1 and 2.62 +/- 0.35 mM, respectively. HPLC analysis shows that both D-Asp(OcHx)-Ala and D-Asp(OBzl)-Ala are fully resistant to degradation for up to 5 h when incubated in the apical media of confluent Caco-2 monolayers. These results demonstrate that it is possible to covalently modify the side chain of one amino acid in an enzymatically stabilized dipeptide with small, aromatic molecules while enabling them to retain their affinity for the oligopeptide transporter. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 18 条
[1]   STRUCTURAL SPECIFICITY OF MUCOSAL-CELL TRANSPORT AND METABOLISM OF PEPTIDE DRUGS - IMPLICATION FOR ORAL PEPTIDE DRUG DELIVERY [J].
BAI, JPF ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1992, 9 (08) :969-978
[2]  
DANIEL H, 1992, J BIOL CHEM, V267, P9565
[3]   UPTAKE OF THE CEPHALOSPORIN, CEPHALEXIN, BY A DIPEPTIDE TRANSPORT CARRIER IN THE HUMAN INTESTINAL-CELL LINE, CACO-2 [J].
DANTZIG, AH ;
BERGIN, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (03) :211-217
[4]   A COMPARISON OF THE AFFINITIES OF DIPEPTIDES AND ANTIBIOTICS FOR THE DIPEPTIDE/TRIPEPTIDE TRANSPORTER IN CACO-2 CELLS [J].
EDDY, EP ;
WOOD, C ;
MILLER, J ;
WILSON, G ;
HIDALGO, IJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 115 (01) :79-86
[5]   EXPRESSION CLONING OF A MAMMALIAN PROTON-COUPLED OLIGOPEPTIDE TRANSPORTER [J].
FEI, YJ ;
KANAI, Y ;
NUSSBERGER, S ;
GANAPATHY, V ;
LEIBACH, FH ;
ROMERO, MF ;
SINGH, SK ;
BORON, WF ;
HEDIGER, MA .
NATURE, 1994, 368 (6471) :563-566
[6]   IS INTESTINAL PEPTIDE-TRANSPORT ENERGIZED BY A PROTON GRADIENT [J].
GANAPATHY, V ;
LEIBACH, FH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (02) :G153-G160
[7]   UPTAKE AND TRANSEPITHELIAL TRANSPORT OF THE ORALLY ABSORBED CEPHALOSPORIN CEPHALEXIN, IN THE HUMAN INTESTINAL-CELL LINE, CACO-2 [J].
GOCHOCO, CH ;
RYAN, FM ;
MILLER, J ;
SMITH, PL ;
HIDALGO, IJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 104 (03) :187-202
[8]   STRUCTURAL REQUIREMENTS FOR INTERACTION WITH THE OLIGOPEPTIDE TRANSPORTER IN CACO-2 CELLS [J].
HIDALGO, IJ ;
BHATNAGAR, P ;
LEE, CP ;
MILLER, J ;
CUCULLINO, G ;
SMITH, PL .
PHARMACEUTICAL RESEARCH, 1995, 12 (02) :317-319
[9]   PASSIVE AND CARRIER-MEDIATED INTESTINAL-ABSORPTION COMPONENTS OF CAPTOPRIL [J].
HU, M ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (12) :1007-1011
[10]   INTERACTION OF RENIN INHIBITORS WITH THE INTESTINAL UPTAKE SYSTEM FOR OLIGOPEPTIDES AND BETA-LACTAM ANTIBIOTICS [J].
KRAMER, W ;
GIRBIG, F ;
GUTJAHR, U ;
KLEEMANN, HW ;
LEIPE, I ;
URBACH, H ;
WAGNER, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (01) :25-30